These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4093908)

  • 41. A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions.
    Fernandez N; Cooper J; Sprinks M; AbdElrahman M; Fiszer D; Kurpisz M; Dealtry G
    Hum Reprod Update; 1999; 5(3):234-48. PubMed ID: 10438108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ontogeny of the mouse immune system in vivo and in vitro studies.
    Tyan ML
    Sov J Dev Biol; 1972; 3(1):19-26. PubMed ID: 4123697
    [No Abstract]   [Full Text] [Related]  

  • 43. Survival of the genetically incompatible fetal allograft.
    Finn R
    Lancet; 1975 Apr; 1(7911):835-8. PubMed ID: 48059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major histocompatibility antigen expression on the bovine placenta: its relationship to abnormal pregnancies and retained placenta.
    Davies CJ; Hill JR; Edwards JL; Schrick FN; Fisher PJ; Eldridge JA; Schlafer DH
    Anim Reprod Sci; 2004 Jul; 82-83():267-80. PubMed ID: 15271459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Why is the fetal allograft not rejected?
    Davies CJ
    J Anim Sci; 2007 Mar; 85(13 Suppl):E32-5. PubMed ID: 17040952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further evaluation of the pregnancy-linked down-regulation of the paternal antigen-specific splenic cytotoxic T lymphocyte activity in allogeneically pregnant mice.
    Parvin M; Isobe K; Goto S; Nakashima I; Tomoda Y
    Microbiol Immunol; 1992; 36(7):757-65. PubMed ID: 1406378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune rejection mechanisms in murine leukemia. I. Timing of tumor cell rejection process relative to the development of humoral and cell-mediated cytotoxic immune responses.
    Ciavarra RP; Terres G
    Int J Cancer; 1984 Nov; 34(5):681-8. PubMed ID: 6500745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model.
    Zenclussen AC; Gerlof K; Zenclussen ML; Sollwedel A; Bertoja AZ; Ritter T; Kotsch K; Leber J; Volk HD
    Am J Pathol; 2005 Mar; 166(3):811-22. PubMed ID: 15743793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues.
    Mattsson R; Mattsson A; Holmdahl R; Scheynius A; Van der Meide PH
    Biol Reprod; 1992 Jun; 46(6):1176-86. PubMed ID: 1391316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fetal histocompatibility antigens and maternal immune responses.
    Billington WD; Bell SC
    Ciba Found Symp; 1983; 96():69-88. PubMed ID: 6343007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of gamma delta T lymphocytes at the maternal-fetal interface.
    Heyborne KD; Cranfill RL; Carding SR; Born WK; O'Brien RL
    J Immunol; 1992 Nov; 149(9):2872-8. PubMed ID: 1401918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of non-rejection of foeto-placental allografts.
    Beer AE; Billingham RE
    Folia Biol (Praha); 1980; 26(4):225-43. PubMed ID: 6157577
    [No Abstract]   [Full Text] [Related]  

  • 53. Sensitized T-lymphocytes against paternal histocompatibility antigens cause intrauterine fetal death and growth retardation.
    Saji F; Nakamuro K; Wakao T; Negoro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Nov; 32(11):1853-8. PubMed ID: 6972424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specificity of allogeneic and xenogeneic cell recognition in the fetal lamb.
    Asantila T; Toivanen P
    J Immunol; 1976 Aug; 117(2):555-62. PubMed ID: 133189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
    Gaines BA; Colson YL; Kaufman CL; Ildstad S
    Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The secretory immune system as part of the placental barrier in the second trimester of pregnancy in humans.
    Ben-Hur H; Gurevich P; Berman V; Tchanyshev R; Gurevich E; Zusman I
    In Vivo; 2001; 15(5):429-35. PubMed ID: 11695242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological mechanisms of survival and "rejection" of the fetal allograft.
    Beer AE; Quebbeman JF
    Mead Johnson Symp Perinat Dev Med; 1986; (24):20-6. PubMed ID: 2943949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunity and pregnancy.
    Gill TJ
    Crit Rev Immunol; 1985; 5(3):201-27. PubMed ID: 3884273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of T helper 2-type cytokines at the maternal-fetal interface.
    Lin H; Mosmann TR; Guilbert L; Tuntipopipat S; Wegmann TG
    J Immunol; 1993 Nov; 151(9):4562-73. PubMed ID: 8409418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on transplantation immunity. IV. Murine natural immunity to lymphoid cells in vivo.
    Pincott CE; Bainbridge DR
    Eur J Immunol; 1980 Apr; 10(4):250-7. PubMed ID: 7398757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.